The 12th International Symposium on Hodgkin Lymphoma (ISHL12) was held in Cologne, Germany, and virtually, on October 22-24 2022, and provided an overview of the most exciting advances in the diagnosis, treatment, biology, and clinical research of Hodgkin lymphoma (HL). This year, the meeting focused on patients with early-stage disease, as well as elderly and frail patients.
View all videos

ISHL12 2022

The 12th International Symposium on Hodgkin Lymphoma
22–24 October 2022 | Cologne, Germany / Online

Our paper is online! MinimuMM-seq: Genome sequencing of circulating tumor cells for minimally invasive molecular characterization of multiple myeloma pathology | Cancer Discivery #mmsm ⁦@LabGhobrial⁩ ⁦@getz_lab⁩ https://aacrjournals.org/cancerdiscovery/article/doi/10.1158/2159-8290.CD-22-0482/711479/MinimuMM-seq-Genome-sequencing-of-circulating

Join us in this week's podcast, where you will hear from experts @Daver_Leukemia, @pvyas_oxford, Alexander Perl & Carsten Müller-Tidow, who discuss mechanisms of resistance to targeted therapies in AML, the role of epigenetics & more.🧬

🎧: http://ow.ly/oT4B50LYqnu

#AMLsm #LeuSM

New Orleans, here we come… 🛫 🧳 Show us how you’re traveling to #ASH22 & reply with a photo of your journey 📸 Whether you’re commuting from your kitchen to the couch, driving from Denver to downtown NOLA, or flying from Foshan to the French Quarter – we want to see it all!

If you're heading to #ASH22 and want to make the most of Twitter whilst you're there, check out our NEW VJSocial Masterclass with leading #HemOnc experts @doctorpemm, @mpdrc & @harrisoncn1📱🩸

https://www.vjhemonc.com/feature/vjsocial-media-masterclass-social-media-strategy/

Load More...

ISHL12 2022

The 12th International Symposium on Hodgkin Lymphoma
22–24 October 2022 | Cologne, Germany / Online
The 12th International Symposium on Hodgkin Lymphoma (ISHL12) was held in Cologne, Germany, and virtually, on October 22-24 2022, and provided an overview of the most exciting advances in the diagnosis, treatment, biology, and clinical research of Hodgkin lymphoma (HL). This year, the meeting focused on patients with early-stage disease, as well as elderly and frail patients.
View all videos

Our paper is online! MinimuMM-seq: Genome sequencing of circulating tumor cells for minimally invasive molecular characterization of multiple myeloma pathology | Cancer Discivery #mmsm ⁦@LabGhobrial⁩ ⁦@getz_lab⁩ https://aacrjournals.org/cancerdiscovery/article/doi/10.1158/2159-8290.CD-22-0482/711479/MinimuMM-seq-Genome-sequencing-of-circulating

Join us in this week's podcast, where you will hear from experts @Daver_Leukemia, @pvyas_oxford, Alexander Perl & Carsten Müller-Tidow, who discuss mechanisms of resistance to targeted therapies in AML, the role of epigenetics & more.🧬

🎧: http://ow.ly/oT4B50LYqnu

#AMLsm #LeuSM

New Orleans, here we come… 🛫 🧳 Show us how you’re traveling to #ASH22 & reply with a photo of your journey 📸 Whether you’re commuting from your kitchen to the couch, driving from Denver to downtown NOLA, or flying from Foshan to the French Quarter – we want to see it all!

If you're heading to #ASH22 and want to make the most of Twitter whilst you're there, check out our NEW VJSocial Masterclass with leading #HemOnc experts @doctorpemm, @mpdrc & @harrisoncn1📱🩸

https://www.vjhemonc.com/feature/vjsocial-media-masterclass-social-media-strategy/

Load More...

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter